Zur Kurzanzeige

2018-04-11Zeitschriftenartikel DOI: 10.25646/6087
Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection
dc.contributor.authorKlingeberg, Anja
dc.contributor.authorNoll, Ines
dc.contributor.authorWillrich, Niklas
dc.contributor.authorFeig, Marcel
dc.contributor.authorEmrich, Dagmar
dc.contributor.authorZill, Edith
dc.contributor.authorKrenz-Weinreich, A.
dc.contributor.authorKalka-Moll, Wiltrud
dc.contributor.authorOberdorfer, Klaus
dc.contributor.authorSchmiemann, Guido
dc.contributor.authorEckmanns, Tim
dc.date.accessioned2019-04-24T05:42:55Z
dc.date.available2019-04-24T05:42:55Z
dc.date.issued2018-04-11none
dc.identifier.other10.3238/arztebl.2018.0494
dc.identifier.urihttp://edoc.rki.de/176904/6118
dc.description.abstractBackground: Routine urine culture testing is not recommended for uncomplicated urinary tract infections (UTIs). As a result, the antibiotic resistance patterns or the organisms causing UTIs are not adequately reflected in routine data. We studied the sensitivity of Escherichia coli (E. coli) to trimethoprim (TMP) and to cotrimoxazole (i.e., trimethoprim/sulfamethoxazole, TMP/SMX) in community-acquired UTI and compared the findings with the resistance data of the Antimicrobial Resistance Surveillance System (ARS). Methods: General practitioners and internists in private practice prospectively recruited all of their adult patients with symptoms of a urinary tract infection from May 2015 to February 2016. Urine specimens from all patients were tested (including urine culture testing and antibiotic susceptibility) and infections were defined as uncomplicated or complicated UTIs. Results: 1245 participants from 58 medical practices were enrolled in the study. Pathogenic organisms were found in the urine of 877 patients, of whom 74.5% had E. coli infections. Among the E.-coli-positive UTIs, 52.4% were classified as uncomplicated and 47.6% as complicated. The prevalence of E. coli that was resistant to TMP and to TMP/SMX in uncomplicated UTIs was 15.2% and 13.0%, respectively, compared to 25.3% and 24.4%, respectively, from all UTIs in ARS in 2015. Study participants who had previously taken antibiotics had the highest prevalence of E. coli resistance (30.9%), followed by those who had two or more UTIs within the past six months (28.9%). Conclusion: E. coli with resistance to TMP was significantly less prevalent among the study patients with uncomplicated UTIs than in the routine data of the ARS. Accordingly, TMP should still be considered as an option for the treatment of uncomplicated UTIs. TMP/SMX is considered the agent of second choice because of its side effects. Surveillance systems based on routine data do not yield a representative sample for the evaluation of the resistance situation in patients with uncomplicated UTIs.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleAntibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infectionnone
dc.typearticle
dc.subtitleA Prospective Cohort Study from 2015/16 (the SARHA Study) Compared With Data From the Antimicrobial Resistance Surveillance System (ARS)none
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6118-7
dc.identifier.doihttp://dx.doi.org/10.25646/6087
dc.type.versionpublishedVersionnone
local.edoc.container-titleDeutsches Ärzteblattnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.aerzteblatt.de/int/archive/article/199040none
local.edoc.container-publisher-nameDeutscher Ärzte-Verlagnone
local.edoc.container-volume115none
local.edoc.container-issue29-30none
local.edoc.container-reportyear2018none
local.edoc.container-year2018none
local.edoc.container-firstpage494none
local.edoc.container-lastpage500none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige